Paediatric Erythema Multiforme: Epidemiological, Clinical and Laboratory Characteristics

被引:27
作者
Siedner-Weintraub, Yael [1 ]
Gross, Itai [1 ]
David, Almog [3 ]
Reif, Shimon [1 ]
Molho-Pessach, Vered [2 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Pediat Div, Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Dept Dermatol, POB 12000, IL-9112001 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
关键词
erythema multiforme; children; erythema multiforme minor; erythema multiforme major; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; CHILDREN; DISTINCT;
D O I
10.2340/00015555-2569
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Erythema multiforme (EM) is an immune-mediated reaction presenting as acrofacial target lesions. Most studies utilize the outdated classification, which includes EM, Stevens-Johnson syndrome and toxic epidermal necrolysis as related entities. We describe here epidemiological, aetiological, clinical, laboratory and treatment characteristics of paediatric EM. This is a retrospective single-centre study, performed between 2000 and 2013. Of 119 children given a diagnosis of EM, only 30 met clinical criteria and were included in this study. Most misdiagnosed cases were non-specific eruptions and urticaria multiforme. Mean age was 11.3 years. Fifty percent had mucosal involvement. An aetiology was observed in half of the patients. Seventy percent of patients were admitted to hospital, 46.7% were treated with systemic steroids. Sixteen percent had recurrent EM. The most common identified infectious agent associated with EM in this study was Mycoplasma pneumonia and the cases associated with this infection may represent the recent entity, mycoplasma-induced rash and mucositis. Association with herpes simplex virus was not observed. Despite being a benign, self-limiting condition, children were over-treated in terms of hospitalization and therapy.
引用
收藏
页码:489 / 492
页数:4
相关论文
共 23 条
  • [11] Read J, 2015, PEDIAT EMERG CARE
  • [12] THE SPECTRUM OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS - A CLINICAL CLASSIFICATION
    ROUJEAU, JC
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) : S28 - S30
  • [13] Rzany B, 1996, BRIT J DERMATOL, V135, P6
  • [14] Samim Firoozeh, 2013, Dent Clin North Am, V57, P583, DOI 10.1016/j.cden.2013.07.001
  • [15] Erythema multiforme due to Mycoplasma pneumoniae infection in two children
    Schalock, Peter C.
    Dinulos, James G. H.
    Pace, Nicole
    Schwarzenberger, Kathryn
    Wenger, Jodi K.
    [J]. PEDIATRIC DERMATOLOGY, 2006, 23 (06) : 546 - 555
  • [16] Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist
    Sokumbi, Olayemi
    Wetter, David A.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (08) : 889 - 902
  • [17] Precipitants in 42 cases of erythema multiforme
    Villiger, RM
    von Vigier, RO
    Ramelli, GP
    Hassink, RI
    Bianchetti, MG
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (11) : 929 - 932
  • [18] Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS']JS)/toxic epidermal necrolysis (TEN)
    Watanabe, Rie
    Watanabe, Hideaki
    Sotozono, Chie
    Kokaze, Akatsuki
    Iijima, Masafumi
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (06) : 889 - 894
  • [19] WESTON WL, 1992, PEDIATRICS, V89, P32
  • [20] WESTON WL, 1989, PEDIATR DERMATOL, V6, P229